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StrokeNeuroimaging of exogenous tracer extravasation has become the technique of choice in preclinical and clin-
ical studies of blood–brain barrier permeability. Such tracers have a larger molecular weight than small ions,
neurotransmitters and many drugs. Therefore, it is assumed that tracer extravasation indicates both perme-
ability to these and the cancelation of the electrical polarization across the barrier. Electrophysiological
anomalies following intracarotideal administration of dehydrocholate, a bile salt causing extravasation of
the albumin-binding tracer Evans blue, seemingly supported this. By contrast, electron microscopic studies
suggested a different hierarchical pattern of blood–brain barrier dysfunction, a milder degree of impairment
being characterized by increased function of the transcellular pathway and a severe degree by opening of the
tight junctions. This would imply that the extravasation of macromolecules can occur before disruption of the
electrical barrier. However, functional evidence for this has been lacking. Here, we further investigated the
electrophysiological anomalies following intracarotideal application of dehydrocholate in rats and found
that it caused focal cerebral ischemia by middle cerebral artery thrombosis, the electrophysiological record-
ings being characteristic of long-lasting spreading depolarization. These observations indicated that
intracarotideal dehydrocholate is not a suitable model to study the isolated dysfunction of the blood–brain
barrier. Second, we studied the topical application of dehydrocholate to the brain and the application of man-
nitol into the carotid artery. In both models, we found signiﬁcant extravasation of Evans blue but no changes
in either extracellular potassium or the CO2-dependent intracortical direct current deﬂection. The latter is as-
sumed to depend on the proton gradient across the barrier in rats which we conﬁrmed in additional exper-
iments in vivo and in vitro. The stability of the extracellular potassium concentration and the CO2-dependent
direct current deﬂection are two functional tests which indicate the integrity of the electrical barrier. Hence,
our results provide functional evidence that the blood–brain barrier opening to large molecules does not
necessarily imply the opening to small ions consistent with the hierarchy of damage in the previous electron
microscopic studies.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license. Introduction
In 1885, Paul Ehrlich showed the lack in permeability of brain ves-
sels to dyes, and, in 1900, Max Lewandowsky postulated a barrier be-
tween blood and neuronal tissue, the so called blood–brain barrier
(BBB) (Ehrlich, 1885; Lewandowsky, 1900). Under physiological con-
ditions, the restrictive nature of the BBB hinders most polar solutes
and macromolecules larger than 400 to 500 Da to enter the brain's
extracellular space (Fig. 1).rlin, Charité Universitätsmedizin
irect.com).
-NC-ND license. It is often assumed that the transfer of hydrophilic molecules
across the dysfunctional BBB largely depends on their size. The basis
of this concept is that the dysfunction of the BBB occurs on the level
of the junctional complexes of which disruption is indeed character-
ized by a size-dependent paracellular passage of molecules into the
brain as shown in experiments with homozygous claudin-5 knockout
mice (Nitta et al., 2003). This concept implies that BBB opening to
macromolecules such as albumin is associated with opening to
small ions such as potassium and protons. Experiments with the
bile salt sodium dehydrocholate (DHC) seemingly supported this.
When injected into the carotid artery, DHC caused extravasation of
the albumin-binding dye Evans blue (Spigelman et al., 1983), and,
electrophysiological recordings revealed marked persistent changes
in the direct current (DC) potential associated with drastically dimin-
ished, subsequent CO2-dependent DC deﬂections (Nita et al., 2004).
Fig. 1. Anatomical structure of the BBB. (A) The BBB is characterized by endothelial cells that have no fenestrae and minimal transcytotic vesicles but mitochondria in abundance.
They line the inner luminal surface of the vessels and are fastened together by continuous, belt-like endothelial cell–cell complexes of adherens and tight junctions (inset). The tight
junctions are composed of a complex of proteins, including transmembrane proteins (claudins and occludins), and zonula occludens proteins (ZO 1, 2, and 3), which bind the trans-
membrane proteins to the actin/myosin cytoskeleton. The junctional adhesion molecules (JAM) are members of the immunoglobulin superfamily and appear to act as cell-adhesion
molecules for leukocytes (Abbott et al., 2010). The adherens junctions include vascular endothelial cadherin (VE-cadherin) which support a structural maintenance of the BBB and
the formation of tight junctions and catenins that link cadherins to skeleton proteins as well as platelet–endothelial cell adherens molecule (PECAM). Additional cellular elements of
the BBB are pericytes which share with the endothelial cells a common capillary basement membrane and astrocytic foot processes which cover the capillaries (Abbott et al., 2006;
Beard et al., 2011; Neuwelt et al., 2011). (B) While the paracellular pathway is normally blocked by the junctional complexes, the trafﬁcking of essential solutes across the BBB ei-
ther into or out of the brain parenchyma occurs by the transcellular pathway, mediated and controlled through speciﬁc transport or carrier molecules in a highly selective fashion.
Dysfunction of the BBB occurs in many brain diseases, including stroke, epilepsy, trauma, infectious and degenerative disorders (Abbott et al., 2006; Cornford and Oldendorf, 1986;
Korn et al., 2005; Neuwelt et al., 2011; Stanimirovic and Friedman, 2012; Tomkins et al., 2001). While it has long been recognized that BBB dysfunction is associated with brain
diseases, only recently the BBB has been suggested as active player in epileptogenesis and neurodegeneration (Ivens et al., 2007; Marchi et al., 2007; Seiffert et al., 2004; Tomkins
et al., 2007; van Vliet et al., 2007).
205E.J. Kang et al. / Neurobiology of Disease 52 (2013) 204–218These electrophysiological anomalies were regarded as a conse-
quence of BBB opening to small ions, canceling the electrical polariza-
tion across the BBB. Normally, the electrical polarization produces a
resting potential difference of ~4 mV between intravascular and in-
terstitial compartment (Revest et al., 1994).Hyperosmolar agents such as mannitol are another experimental
tool causing dysfunction of the BBB. Mannitol was indeed shown to
cause functional changes in key components of the junctional com-
plexes such as β-catenin which could lead to the junctions' opening
(Farkas et al., 2005). However, previous electron microscopic studies
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suggested a different hierarchical pattern of BBB dysfunction. The
milder degree of impairment appeared to be the leakage of intravas-
cular molecules into the brain's extracellular space by increased func-
tion of the transcellular pathway due to vesicular transcytosis and
formation of transendothelial channels (Farrell and Shivers, 1984;
Houthoff et al., 1982). More severe damage was characterized by
the disruption of tight junctions with widened interendothelial junc-
tional clefts, partially fragmented, necrotic endothelial cells in the
process of desquamation, vasospastic smooth muscle cells and plate-
let activation with attached microthrombi in some arterial segments
(Lossinsky et al., 1995). To our knowledge, the functional evidence
for this hierarchy of damage has been lacking. If such a hierarchy oc-
curs, the milder degree of BBB dysfunction should be characterized by
the extravasation of macromolecules through increased function of
the transcellular pathway in the presence of a closed electrical barrier.
The electrical barrier between intravascular and interstitial compart-
ment is characterized by selective permeabilities to small ions in a
similar fashion to cellular membranes. Hence, the disruption of the
electrical barrier would imply either the opening of tight junctions
or the lysis of endothelial cells.
Therefore, we investigated the electrophysiological responses
induced by intracarotideal DHC in rats in more detail and found
that they are secondary to cerebral ischemia. This implied that
intracarotideal application of DHC is not a suitable model to study
the isolated dysfunction of the BBB. We then investigated further
whether the CO2-dependent intracortical DC deﬂection in rats, the
slowly changing potential difference between the brain extracellular
space and an external reference, is a diffusion potential across the
BBB determined by the product of a constant and the proton gradient
between intravascular and interstitial compartment (Tschirgi and
Taylor, 1958), and can thus be used as functional marker for the intact
electrical barrier. Finally, we studied whether opening of the BBB to
Evans blue by either topical application of DHC to the brain or
intracarotideal infusion of mannitol is associated with (i) a rise in
the extracellular potassium concentration ([K+]o), and (ii) a loss of
the CO2-dependent intracortical DC deﬂection as two independent
functional tests for the integrity of the electrical barrier.
Materials and methods
In vivo experiments, animal preparation
All animal experiments were approved by the Governmental
Animal Care and Use Committee (Landesamt für Arbeitsschutz,Fig. 2. Intracarotideal application of DHC (17.5%, 1 ml). (A and B) Cannulation of the externa
carotid artery (ICA). After the skin incision, the sternomastoid and paratracheal muscles
sternomastoid, paratracheal, and digastric muscles which contains the carotid artery and its
The medially located vagus nerve was separated from the common carotid artery (CCA). Th
medial to it as well as the posterolaterally located occipital artery (OA), which normally
pterygopalatine artery (PA), the lateral branch of the internal carotid artery, which does n
delivered to the brain. Two sutures were looped around the external carotid artery to close
a small incision was made in the external carotid artery between the two sutures and a polye
toward the bifurcation. Eventually, the knots of the sutures were tied and a saline solution, w
it open. (C) In 120 animals, an open cranial window was established caudally. The dura ma
were positioned to record changes in intracortical DC-ECoG, [K+]o or pH. In addition, the
laser-Doppler ﬂow probe (LDF 2). The epidural DC-ECoG was recorded rostrally with an A
probe measured rCBF (LDF 1). In some experiments, SD was artiﬁcially triggered at a small
dow to the medially located recording sites. (D) Near-complete arrest of the pial arterial circ
dow). Note the paleness of the cortex and the massive constrictions of the pial artery in the
Evans blue was administered before intracarotideal injection of DHC. Note the extravasation
of the ipsilateral middle cerebral artery and its branches after intracarotideal DHC. (G) Mult
ical of focal cerebral ischemia. In response to DHC, rCBF showed ﬁrst an increase followed by
the drop in rCBF typical of a systemic hypertension which aims at compensating for the fo
followed by a sudden, marked and long-lasting increase to ~50 mM typical of an SD in ische
DC-ECoG recordings. Similar to the intracortical recordings, the epidural (extracerebral) ele
component of the electroencephalogram showed ﬁrst epileptic spikes after the drop in rCB
ileptic spikes are given at a higher temporal resolution. (I) At a higher temporal resolution,
not possible however to determine the propagation velocity because the exact point remaiGesundheitsschutz und technische Sicherheit Berlin). The animals
were housed in groups (two to four animals per cage) under a
12-hour light–dark cycle with food and tap water available ad libitum.
Hundred and nineteen male Wistar rats (250–400 g; Charles River
Laboratories, Wilmington, MA, USA) were anesthetized with
100 mg/kg thiopental-sodium intraperitoneally (Trapanal, BYK Phar-
maceuticals, Konstanz, Germany), tracheotomized, and artiﬁcially
ventilated (Effenberger Rodent Respirator, Effenberger med.-Techn.
Gerätebau, Pfafﬁng/Attel, Germany). Another ten male Wistar rats
were anesthetized with isoﬂurane (1.5% to 2.0% in 30% O2 and 70%
N2O) and allowed to breathe spontaneously. Wounds were treated
with lidocainehydrochloride gel (2%; Astra GmBH, Wedel, Germany).
End-expiratory CO2 pressure (Heyer CO2 Monitor EGM I, Bad Ems,
Germany) was adjusted to ~35 mm Hg. Body temperature was
maintained at 38.0±0.5 °C using a heating pad (Temperature Control
FHC, Bowdoinham, ME, USA). The left femoral artery was cannulated
to monitor the systemic arterial pressure (Pressure Monitor BP-1,
World Precision Instruments, Berlin, Germany) and the femoral vein
to administer Evans blue. Serial blood gas analyses were performed
to measure arterial partial pressure of O2 (paO2), arterial partial pres-
sure of CO2 (paCO2) and pH using a Compact 1 Blood Gas Analyzer
(AVL Medizintechnik GmbH, Bad Homberg, Germany). The level of
anesthesia was controlled by assessing motor and blood pressure re-
sponses to tail pinch and if necessary, additional doses of thiopental
(25 mg/kg) were applied or isoﬂurane was increased in the inspired
air. Animals were immediately killed after the experiment by intrave-
nous administration of concentrated KCl solution unless they died
spontaneously as stated in the Results section.
Cranial window preparation
A 5×4 mm cranial windowwas performed over the somatosensory
cortex using a saline-cooled drill as described previously (Fig. 2C)
(Dreier et al., 2002; Oliveira-Ferreira et al., 2010). In 120 animals, the
cranial window was open which allowed the placement of ion-
selective microelectrodes. In 9 animals, the window was closed and
coveredwith a glass slip to image the pial arterioles using a CCD camera
(Leica DFC300 FX Digital Color Camera, Leica Microsystems AG,
CH-9435, Heerbrugg, Switzerland) connected to the microscope (Leica
MZ16 FA, Leica Microsystems) and using Leica Application Multifocus
module software. In animals equipped with a closed cranial window
and 95 animals with an open window, the dura mater was removed
to expose the cortex to artiﬁcial cerebrospinal ﬂuid (aCSF) (preparation
type 2) whereas in the remaining 25 animals with an open window
only two slits were cut in the dura to position the microelectrodesl carotid artery (ECA) in a retrograde manner for the application of drugs to the internal
(M) were retracted with silk sutures to open the triangle-shaped area between the
branches. A small lateral part of the hyoid bone was removed to improve the visibility.
e superior thyroid artery (STA), which comes off the external carotid artery and runs
branches from the carotid bifurcation, were ligated with a silk suture. Moreover, the
ot supply the brain, was ligated to ensure that drugs injected into the catheter will be
the vessel in a reversible manner by gently pulling the sutures upward. Subsequently,
thylene catheter was inserted in a retrograde manner. The catheter was pushed further
armed-up to body temperature, was continuously infused through the catheter to keep
ter was cut and the cortical surface exposed to aCSF. One or two glass microelectrodes
subdural DC-ECoG was measured with an Ag/AgCl wire (not shown) and rCBF with a
g/AgCl electrode on the dura. Neighboring this electrode, another laser-Doppler ﬂow
lateral window by either pinprick or KCl (3 M) solution and propagated from this win-
ulation after intracarotideal application of DHC (experiment with a closed cranial win-
window area (arrows) after DHC. (E) Representative brain slice of an animal in which
of Evans blue in both hemispheres. (F) The post mortem analysis revealed a thrombosis
imodal neuromonitoring during intracarotideal DHC application indicated changes typ-
a marked long-lasting drop. The mean arterial pressure increased simultaneously with
cal cerebral ischemia. After the drop in rCBF, [K+]o displayed ﬁrst a shallow increase
mic tissue. The SD is observed as a large negative change (~20 mV) in the intracortical
ctroencephalogram (EEG) displayed a long-lasting DC negativity during the SD. The AC
F followed by a silencing of the spontaneous activity when the SD started. (H) The ep-
it can also be seen that the SD ran from the rostral to the caudal microelectrode. It was
ned unknown where the SD originated after the intracarotideal DHC application.
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superfused with aCSF containing in mM: 127.5 NaCl, 24.5 NaHCO3,
6.7 urea, 3.7 glucose, 3 KCl, 1.5 CaCl2, and 1.2 MgCl2. The aCSF was
equilibrated with a gas mixture containing 6% O2, 5.9% CO2, and
87.5% N2 to achieve physiological levels of pO2, pCO2 and pH. Levels
of pO2 between 90 and 130 mm Hg, pCO2 between 35 and
45 mm Hg, and pH between 7.35 and 7.45 were accepted as
physiological.
To measure epidural ﬁeld potential changes, a second small win-
dow (∅2 mm)was rostrally established where the dura remained in-
tact and an Ag/AgCl electrode was placed on the dura (Fig. 2C).
Neighboring this electrode, the bone was thinned to position an addi-
tional laser-Doppler ﬂow probe.
SD was triggered at a small, lateral cranial window as shown in
Fig. 2C by either pin prick (n=4) or a drop of concentrated KCl
(3 M) solution (n=5).Cannulation of the external carotid artery
In 32 animals, the right external carotid artery was cannulated in a
retrograde manner, as described by Bullard et al. (1984) and
explained in Figs. 2A and B. The retrograde cannulation of the exter-
nal carotid artery allowed the infusion of DHC (n=16) or mannitol
(n=16) into the internal carotid artery.Animal recording techniques
Regional cerebral blood ﬂow (rCBF) was continuously monitored
with one laser-Doppler ﬂow probe (Periﬂux 4001, Perimed, Järfälla,
Sweden) at the caudal cranial window and another optional probe at
the rostral recording site (Fig. 2C). The subdural DC/alternating current
(AC)-electrocorticogram(ECoG) (bandpass: 0–45 Hz) at the caudalwin-
dow (Dreier et al., 2002) and the epidural DC/AC-ECoG at the rostral
window were measured with Ag/AgCl electrodes. In the closed cranial
windows, the subdural electrode was placed in the space between the
cortex and the coverslip. Changes in [K+]o, the extracellular pH and the
intracortical DC/AC-ECoG (bandpass: 0 to 45 Hz)were recorded in a cor-
tical depth of 300 μm with ion-selective microelectrodes which were
prepared and tested as described previously from double-barreled
thetaglass capillaries (Kugelstätter, Garching, Germany) (Heinemann
and Arens, 1992; Lux and Neher, 1973; Windmuller et al., 2005). Potas-
sium ionophore I-cocktail A andhydrogen ionophore I-cocktail A (Fluka/
Sigma-Aldrich) ion exchangers were used formanufacturing potassium-
and pH-selective microelectrodes, respectively. An Ag/AgCl ground elec-
trode was placed in the neck. The electrodes were connected to a differ-
ential ampliﬁer (Jens Meyer, Munich, Germany). Analog-to-digital
conversion was performed using a Power 1401 (Cambridge Electronic
Design Limited, Cambridge, UK). Systemic arterial blood pressure as
well as local cerebral ion, voltage and rCBF changes were continuously
recorded using a personal computer and Spike 2 software (version 6,
Cambridge Electronic Design Limited).Experimental paradigms
Hypercapnic episodes were induced by ventilation with a gas mix-
ture containing 21% O2, 10% CO2, and 69% N2 for 5 min. Further details
of the experimental paradigms are given in the Supplemental materi-
al and methods (1: Experimental paradigms of intracarotideal DHC
infusion, topical application of DHC to the brain and intracarotideal
mannitol infusion, assessment of Evans blue extravasation). Moreover,
the experimental paradigms of these experiments and the experi-
mental paradigm of the pharmacological experiments are given in
Supplemental Fig. 1.Brain slices
For in vitro electrophysiological recordings, male Wistar rats
(250–400 g, n=6) were deeply anesthetized with isoﬂurane and de-
capitated. Brains were quickly removed, and coronal slices of 400 μm
thickness were prepared from the somatosensory cortex using a
vibrating-blade tissue slicer (Vibroslice, Campden Instruments, Lough-
borough, UK). Slices were perfused with prewarmed aCSF in an
interface-type recording chamber and maintained in a humidiﬁed,
carbogenated (95% O2 and 5% CO2) atmosphere at 34.5 °C. The compo-
sition of the aCSFwas (inmM): 129 NaCl, 21 NaHCO3, 10 glucose, 3 KCl,
1.8MgSO4, 1.6 CaCl2, and 1.25 NaH2PO4. Prior to the onset of the record-
ings, the tissue was given time to recover from the preparation proce-
dure for at least 1 h (Kirov et al., 1999; Schurr et al., 1984; Taylor
et al., 1999). To ensure viability of the tissue, evoked ﬁeld potentials in
neocortical layers II/III were assessed after stimulation at the boundary
of layer VI to the subjacent white matter using a bipolar platinum elec-
trode. Slices were accepted for further investigation if the ﬁeld potential
was at least 1.5 mV in amplitude. In order to simultaneously measure
extracellular changes in ﬁeld potential (DC/AC-ECoG), [K+]o, [Ca2+]o
as well as pH, potassium, calcium and pH-selective microelectrodes
were prepared and tested as mentioned above. Calcium ionophore
I-cocktail A (Fluka/Sigma-Aldrich) ion exchanger was used for
manufacturing the calcium-selectivemicroelectrodes. To test the effects
of extracellular acidiﬁcation caused by increased ambient pCO2, the gas
mixture was switched every 5 min from 80% O2, 5% CO2, and 15% N2 to
80% O2, 20% CO2 and 0% N2.
Data analysis and statistics
DC-potentials were analyzed as absolute changes and rCBF was
calculated as percentage change from baseline (=100%). Ion concen-
tration changes were calculated from the voltage changes using the
Nernst equation. Pb0.05 was accepted as statistically signiﬁcant. De-
tails of the statistical analysis are given in the text below.
Results
Intracarotideal application of DHC causes focal cerebral ischemia
It has been shown previously that intracarotideal application of
DHC (17.5%, 1 ml) causes Evans blue dye extravasation in rats
(Spigelman et al., 1983). Electrophysiological recordings at the scalp
in cats revealed that a similar protocol of intracarotideal DHC admin-
istration generated electrophysiological anomalies which could indi-
cate the cancelation of the electrical potential across the BBB (Nita
et al., 2004).
To further characterize the electrophysiological responses to
intracarotideal application of DHC (17.5%, 1 ml, infused over 1 min
(Spigelman et al., 1983)), we implanted an open cranial window in
artiﬁcially ventilated rats under thiopental anesthesia, and measured
intracortical DC and AC signals, intracortical [K+]o and rCBF. The
protocol started with two hypercapnic episodes as explained in the
Supplemental material and methods (1: Experimental paradigms of
intracarotideal DHC infusion, topical application of DHC to the brain
and intracarotideal mannitol infusion, assessment of Evans blue extrava-
sation) and Supplemental Fig. 1.
Intracarotideal DHC induced a short initial increase of rCBF to 365
(274, 413) % (median, ﬁrst and third quartile) in all 6 experiments
followed by a marked drop to 27 (25, 41) % after 31 (27, 86) s in 5
of 6 experiments (Fig. 2G). A shallow increase in baseline [K+]o
from 3 to 8.5 (5.6, 11.9) mM started simultaneously with the decrease
in rCBF. This was accompanied by ictal epileptic ﬁeld potentials with
an amplitude of −2.4 (−1.7, −5.2) mV, a spike duration of 65 (63,
68) ms, and a spike frequency of 0.9 (0.6, 1.8) Hz (Fig. 2H) followed
by a suppression of spontaneous activity. Moreover, a signiﬁcant
Fig. 3. Association between the type of the rCBF response to hypercapnia and the type of the dura defect at the cranial window. At the bottom, the position of the caudal cranial
window in relation to the brain is depicted. The cranial window is surrounded by a wax wall and dental cement. Above, on the left side, the type 1 preparation is given in
which only two small slits (red arrow) were cut in the dura (thick black layer and black arrow) to position the microelectrodes, whereas, on the right side, the type 2 preparation
is given in which the dura was removed to expose the cortex to the aCSF. At the top of the ﬁgure, a contingency table is shown in a monitor which displays the hyperemic rCBF
responses to hypercapnia in the upper row and the hypoemic rCBF responses in the lower row while the columns give the two different preparation types. According to the dis-
tribution in the four ﬁelds, the hyperemic type 1-rCBF response to hypercapnia was signiﬁcantly associated with the preparation type 1 and the hypoemic type 2-rCBF response
with the preparation type 2 (P=0.001, n=95, Chi-Square test with Yates correction for continuity).
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203) mm Hg (Pb0.001, n=5, Paired t-test) accompanied the de-
crease in rCBF typical of a compensatory systemic hypertension. In
all ﬁve animals, which displayed a drop in rCBF, 32 (21, 74) s after
its onset, we observed a sharp saddle-shaped negative intracortical
DC shift with an amplitude of −20.5 (−18.9, −22.0) mV accompa-
nied by a steep increase in [K+]o to 53.5 (40.9, 57.4) mM typical of
a spreading depolarization (SD) in ischemic tissue (Dreier, 2011;
Hansen and Lauritzen, 1984) (Fig. 2G). This intracortical DC shift
spread between the rostral and the caudal microelectrode with a
latency of 13 (4, 39) s typical of SD (Fig. 2I). Epidural recordings,
performed remotely from the open cranial window, showed ﬁrst a
positive DC shift of 0.6 (0.2, 1.0) mV which accompanied the onset
of the rCBF decrease. After 31 (24, 78) s, this epidural DC positivity
was succeeded by a negativity of −3.2 (−7.2, −2.6) mV which
persisted until the end of the experiment (Fig. 2G).
Three of the ﬁve animals were sacriﬁced after an observational pe-
riod of 60 min during which the DC negativity, the elevated level of
[K+]o and the suppression of spontaneous activity had not recovered.
The remaining two animals died 7.3 and 10.7 min after DHC applica-
tion. Marked Evans blue dye extravasation was observed in the whole
brain in all animals (Fig. 2E).
For a comparison with the ischemic SDs following intracarotideal
DHC, we recorded a pinprick-induced SD under physiological condi-
tions in four additional rats. This SDwas characterized by a sharp neg-
ative intracortical DC-shift of −16.7 (−16.4, −17.2) mV lasting for
85 (81, 97) s, a steep rise in [K+]o to 59.0 (50.7, 67.6) mM and atransient rise of rCBF to 250 (241, 256) %. After the spreading hyper-
emia, rCBF showed a long-lasting spreading oligemia to 84 (81, 87) %.
Epidurally, the SD was associated with a small initial negative DC shift
of−0.3 (−0.6,−0.2) mV lasting for 67 (57, 100) s followed by a per-
sistent positive DC shift of 2.3 (2.0, 2.8) mV lasting for at least 64 (52,
67) min as shown in Fig. 4A.
Subsequently, we tested the infusion of lower concentrations and
volumes of DHC into the carotid artery. Because we aimed at
performing a histological analysis to assess the ischemic injury 24 h
after the infusion of DHC, the animals were anesthetized with
isoﬂurane in these experiments, and they were not tracheotomized
but breathed spontaneously, which would have allowed us to wake
them up after the experiment. But, the animals died 7.1 (5.4, 10.3)
min, 10.2 (8.0, 11.7) min and 20.1 min after administration of DHC
17.5% (0.5 ml, n=4), DHC 15% (0.5 ml, n=5) and DHC 10% (0.5 ml,
n=1), respectively. All animals showed subdural DC/AC-ECoG and
rCBF changes typical of focal cerebral ischemia before they died
(data not shown).
Subsequently, we implanted a closed cranial window in 9 animals
to image the pial vascular changes following intracarotideal applica-
tion of DHC. All animals showed subdural DC/AC-ECoG and rCBF
changes typical of focal cerebral ischemia before they died (data not
shown). Videomicroscopy revealed an arrest of the pial circulation
following DHC (Fig. 2D). After the experiment, the animals were
transcardially perfused with 150 ml of physiological saline solution.
Post mortem analysis of the brains revealed a thrombosis of the ipsi-
lateral middle cerebral artery and its branches (Fig. 2F). These
Fig. 4. (A) SD was elicited by a pinprick in four animals to study the epidural DC/AC-EEG changes simultaneously with the intracortical DC/AC-ECoG, [K+]o and rCBF changes in
healthy tissue during SD. The SD was followed by a long-lasting spreading oligemia. Notably, the epidural DC potential (green trace) showed an initial short-lasting negativity
followed by a positivity. The latter appeared to accompany the spreading oligemia and lasted for more than 1 h. (B) Hypercapnic episodes under control conditions. The increase
in end-expiratory pCO2 indicated the hypercapnic episode (upper traces). The physiological hyperemic rCBF change in response to hypercapnia was termed the type 1-rCBF
response (upper part) and the unusual hypoemic rCBF change the type 2-rCBF response (lower part) (red traces). Low-frequency vascular ﬂuctuations (LF-VF, bandpass:
0.05–0.1 Hz) and high-frequency vascular ﬂuctuations (HF-VF, bandpass: 0.5–5 Hz) signiﬁcantly increased during hypercapnia when the normal type 1-rCBF response was ob-
served. By contrast, they showed a strong increase only after the hypercapnic episode when the hypoemic type 2-rCBF response occurred. Whereas the CO2-dependent intracortical
DC potential was independent of the type of rCBF response to hypercapnia, the CO2-dependent epidural DC potential appeared to follow the rCBF changes. The power of the spon-
taneous activity (AC-EEG and AC-ECoG) only decreased signiﬁcantly when the type 2-rCBF response occurred. In this example for the type 2-rCBF response, both epidural and
intracortical DC/AC-ECoG show a slight decline more than 5 min before the hypercapnia. This is likely an artifact. Asterisk: typical positive CO2-dependent intracortical DC shift
induced by hypercapnia. In the top row, the same CO2-dependent intracortical DC deﬂection is given at a higher resolution. It is seen that hypercapnia (bar, 5 min) induced a pos-
itive intracortical DC deﬂection with a steep initial increase followed by a plateau and a recovery phase.
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bral ischemia in rats and cannot be used to selectively study the open-
ing of the electrical barrier.
The CO2-dependent intracortical DC deﬂection in the rat does not depend
on changes in rCBF
Next, we investigated whether and how the CO2-dependent
intracortical DC deﬂection is generated at the BBB in rats, and wheth-
er it can be used as a functional tool to assess the integrity of the elec-
trical barrier (Tschirgi and Taylor, 1958).
Notably, there are important species differences in the CO2-
dependent intracortical DC deﬂection. Whereas rats, rabbits, goats
and dogs displayed a positive DC deﬂection in response to hypercap-
nia, which depended in a linear fashion on the proton gradient across
the BBB, cats and monkeys displayed a negative DC deﬂection, which
appeared to depend on the level of rCBF (Besson et al., 1970; Held
et al., 1964; Messeter and Siesjo, 1971; Tschirgi and Taylor, 1958;
Woody et al., 1970). However, whether the level of rCBF also inﬂu-
ences the CO2-dependent intracortical DC deﬂection in rats has not
been investigated. In the present study, we were able to exclude
this possibility by an artifact related to the size of the dura defect in
our open cranial window preparations.
Thus, we did not only observe the normal hyperemic response to
hypercapnia (type 1) in 53 animals but also an unusual, mildly
hypoemic response (type 2) in 42 animals. In all 95 experiments, an-
imals were anesthetized with thiopental, artiﬁcially ventilated and
equipped with an open cranial window, rCBF was measured at this
window, the ﬁrst hypercapnic episode occurred under control condi-
tions and this hypercapnic episode was indicated by a marked in-
crease in end-expiratory pCO2 (Fig. 4B).
The two different types of rCBF responses are shown in Fig. 4B and
compared in Table 1B. In addition to the abnormal hypoemic rCBF
change, the type 2 response was characterized by a signiﬁcant
hypercapnia-associated reduction in the power of spontaneous activ-
ity (Table 1B3). Table 1A gives the pooled changes in the systemic pa-
rameters during the ﬁrst control episode of hypercapnia for both the
group of animals, which displayed the type 1-rCBF response, and the
group of animals, which displayed the type 2-rCBF response. No sig-
niﬁcant differences in the changes of the systemic parameters during
hypercapnia were found between the two groups (Table 1B1). This
suggested that a local factor at the window site might have been re-
sponsible for the different rCBF responses. We therefore investigated
whether the two different rCBF responses were associated with the
two different preparation techniques for the open cranial window
which we had performed in this study. In preparation type 1, only
two small slits had been cut in the dura mater to position the micro-
electrodes in the parenchyma while, in preparation type 2, a larger
part of the dura was removed to allow the topical application of
drugs to the brain. As illustrated in Fig. 3, there was a signiﬁcant asso-
ciation of the type 1-rCBF response with the type 1 preparation and of
the type 2-rCBF response with the type 2 preparation, respectively
(P=0.001, n=95, Chi-Square test with Yates correction for continu-
ity). That the type of rCBF response depended on the type of defect in
the dura mater suggests a relation with the mild brain swelling that
results from the increase in cerebral blood volume and a mild uptake
of water during hypercapnia (Lu et al., 2009; Paljarvi et al., 1982). This
swelling might have caused a compression of the brain at the rim of
the dura defect when the defect was larger. Unfortunately, this pre-
cluded a further meaningful analysis of hypercapnia-induced changes
in rCBF and spontaneous activity in experiments in which preparation
type 2 had been performed. The hypercapnia-induced intracortical
DC-shift could nevertheless be analyzed in all groups because it did
not show any difference between the two types of rCBF responses
(Table 1B2). Notably, this limitation of our study was not only
unfavorable. That the hypo- and hyperemic rCBF responses wereassociated with CO2-dependent intracortical DC deﬂections of the
same polarity and magnitude allowed us to exclude the possibility
that the intracortical DC deﬂection is inﬂuenced by changes in rCBF
in the rat.
In contrast to the CO2-dependent intracortical DC deﬂection, the
CO2-dependent epidural DC deﬂection, an extracerebrally recorded
volume conducted signal which is modiﬁed by extracerebral factors,
showed a clear dependence on the type of rCBF response. Whereas
the epidural DC deﬂection associated with the type 1-rCBF response
had the same polarity as the intracortical DC deﬂection, the epidural
DC deﬂection associated with the type 2-rCBF response had the oppo-
site polarity (Fig. 4B). These differences were statistically signiﬁcant
(Table 1B2).
Evidence in vivo against neurons as generators of the intracortical
CO2-dependent DC deﬂection (type 2 preparation)
If neurons generated the hypercapnia-induced positive, intracortical
DC-shift in a similar fashion to an extracellular ﬁeld postsynaptic poten-
tial, hypercapnia should induce an uneven, zonal hyperpolarization of
the neurons leading to axial and net transmembrane currents. Hyperpo-
larization could result from activation of neuronal K+ channels. We
therefore tested in vivo the effect of amiloride (n=6), an inhibitor of
acid-sensing ion channels, and of inhibitors of major K+ channels on
the hypercapnia-induced intracortical DC shift. Speciﬁcally, we applied
tolbutamide (n=5), an inhibitor of ATP-sensitive K+ channels, apamin
(n=5), an inhibitor of small conductance Ca2+-sensitive K+ channels
(SK) and tetraethylammonium (TEA) (n=5), an inhibitor of big con-
ductance Ca2+-sensitive K+ channels (BK). However, neither sham
controls nor animals, inwhich these channel blockerswere topically ap-
plied to the brain, showed any difference between the hypercapnia-
induced intracortical DC-shift associated with the ﬁrst control episode
of hypercapnia and the second episode of hypercapnia after drug appli-
cation. The effects of these drugs on baseline [K+]o are shown in
Table 1C.
Evidence in vivo against astrocytes as generators of the intracortical
CO2-dependent DC deﬂection (type 2 preparation)
DC potentials can also result from current ﬂow driven by inhomo-
geneous polarization across the glial syncytium (Dietzel et al., 1989;
Orkand et al., 1966). Such DC-shifts depend on potassium and chlo-
ride uptake by astrocytes. We therefore tested in vivo whether a
major inhibitor of potassium uptake by astrocytes and a chloride
channel blocker would change the CO2-dependent intracortical DC
deﬂection in vivo. Speciﬁcally, we applied barium, an inhibitor of in-
wardly rectifying K+ channels (n=6), and DIDS, an inhibitor of astro-
cytic Cl− channels (n=5) (Walz and Wuttke, 1999). None of these
drugs had any effect on the intracortical DC deﬂection.
Moreover, we tested the effect of topically applying the Na,
K-ATPase inhibitor ouabain to the brain in 6 animals. Ouabain was ad-
ministered at a concentration of 10 μM in which it selectively inhibits
the neuronal α2 and the astrocytic α3 isoforms in rats (Blanco and
Mercer, 1998). We found no reduction of the intracortical CO2-
dependent DC deﬂection. The effects of the different drugs on base-
line [K+]o are shown in Table 1C.
Indirect evidence in vitro that the CO2-dependent intracortical DC
deﬂection is generated at the BBB
In six neocortical slices from six different rats,we determined theDC,
pH, [Ca2+]o and [K+]o signals in response to a change froma gasmixture
containing 80% O2, 5% CO2 and 15% N2 to a gas mixture containing 80%
O2, 20% CO2 and 0% N2. During hypercapnia, the intracortical pH fell sig-
niﬁcantly from 7.398 (7.398, 7.423) to 6.982 (6.970, 7.106) pH units
(Pb0.001, n=6, Paired t-test), [K+]o signiﬁcantly increased from 3.0
Table 1
A Changes of systemic parameters under hypercapnia
Before hypercapnia Hypercapnia n P Test
PaCO2 (mm Hg) 40.3
(36.0, 44.3)
72.3
(59.5, 79.5)
74 b0.001 Paired t-test
PaO2 (mm Hg) 100.9
(89.1, 116.2)
79.8
(69.3, 96.6)
80 b0.001 Paired t-test
pH 7.352
(7.319, 7.387)
7.160
(7.134, 7.180)
78 b0.001 Wilcoxon signed rank test
MAP (mm Hg) 114
(104, 126)
95
(85, 103)
80 b0.001 Wilcoxon signed rank test
B1 Comparison between type 1- and type 2-rCBF response (systemic parameters)
Type 1-rCBF response Type 2-rCBF response
n Before hypercapnia Hypercapnia n Before hypercapnia Hypercapnia P
PaCO2 (mm Hg) 40 41.9
(37.6, 47.4)
76.8
(66.5, 82.9)
34 38.8
(33.5, 41.1)
66.9
(55.9, 78.4)
n.s.
PaO2 (mm Hg) 44 98.2
(88.8, 114.6)
74.9
(67.8, 86.6)
36 103.2
(94.0, 118.7)
87.8
(70.1, 105.0)
n.s.
pH 41 7.351
(7.300, 7.381)
7.164
(7.134, 7.185)
36 7.346
(7.322, 7.380)
7.158
(7.138, 7.176)
n.s.
MAP (mm Hg) 40 115
(105, 126)
95
(84, 104)
36 115
(102, 127)
95
(85, 101)
n.s.
B2 Comparison between type 1- and type 2-rCBF response (electrophysiological parameters)
Type 1-rCBF resp. Type2-rCBF resp.
n Hypercapnia−before hypercapnia n Hypercapnia−before hypercapnia P Test
Intracortical DC (mV) 52 3.1
(2.7, 3.6)
41 3.0
(2.5, 3.4)
n.s. t-test
Epidural DC (mV) 42 0.5
(0.2, 0.7)
27 −0.5
(0.4, −0.4)
=0.002 Mann–Whitney rank sum test
B3 Type 1-rCBF response Type2-rCBF response
n Hypercapnia
(change compared to baseline)
P n Hypercapnia
(change compared to baseline)
P Test
rCBF reactivity
(%/mm Hg paCO2)
53 6.1
(5.2, 7.4)
b0.001 Wilcoxon Signed Rank Sum tests
rCBF change (%) 53 186
(157, 221)
b0.001 42 84
(74, 88)
b0.001
Power of LF-VF (%) 53 247
(152, 418)
b0.001 42 134
(95, 246)
=0.002
Power of HF-VF (%) 53 186
(123, 296)
b0.001 42 117
(92, 133)
=0.006
Power of spontaneous
activity (%)
52 101
(73, 113)
n.s. 41 76
(50, 102)
=0.002
[K+]o (mM) 42 0.0
(−0.1, 0.1)
n.s. 32 0.1
(−0.1, 0.2)
n.s.
C Drugs Changes of baseline [K+]o (mM)
Baseline [K+]o after drug application n P Test
Sham control aCSF 3.2
(3.0, 3.6)
16 n.s. One way analysis of variance with
Bonferroni post-hoc test
Neuronal channel blockers Apamin 3.6
(3.2, 4.1)
5 n.s.
Amiloride 3.5
(3.3, 3.7)
6 n.s.
Tolbutamide 3.1
(3.0, 3.1)
5 n.s.
TEA 3.1
(2.9, 3.3)
5 n.s.
Ouabain 5.0
(4.7, 5.2)
6 =0.01
Astrocytic channel blocker Barium 2.1
(2.1, 2.5)
6 =0.01
DIDS 3.6
(3.6, 3.7)
5 n.s.
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and [Ca2+]o increased from 1.57 (1.56, 1.58) to 1.87 (1.72, 2.44) mM
(n=3) but the latterwas not statistically signiﬁcant. These observations
corresponded well with previous ﬁndings of an increase in [K+]o inbrain slices (Lehmenkühler et al., 1989). In contrast to the positive
hypercapnia-induced intracortical DC deﬂection in vivo, the brain slices
always displayed a small and steady negative hypercapnia-induced
intracortical DC deﬂection of −0.61 (−0.54, −0.71) (Pb0.001, n=6,
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itive hypercapnia-induced intracortical DC deﬂection in vivo is generat-
ed at the BBB because brain slices lack an intact BBB.
Evidence that the CO2-dependent intracortical DC deﬂection represents a
diffusion potential related to the proton gradient across the BBB in rats
Next, we investigated further whether the CO2-dependent
intracortical DC deﬂection in rats is a diffusion potential across the
BBB determined by the following empirical Nernstian formula
(Tschirgi and Taylor, 1958) and can thus be used as a tool to assess
the BBB permeability to protons:
Δ potential difference ¼ 29 5ð Þ log10
Hþ
 
intravascular
Hþ½ interstitial
ð1Þ
Δ potential difference ¼ 29 5ð Þ ΔpHinterstitial−ΔpHintravascularð Þ: ð2Þ
In 16 experiments, we measured the intracortical change in pH
during hypercapnia using pH-selective microelectrodes (Fig. 5B).
We found a signiﬁcant decrease by 0.091 (0.021, 0.168) pH units
(P=0.001, Paired t-test). This pH decrease was signiﬁcantly smaller
than the arterial pH decrease of 0.192 (0.162, 0.210) (Pb0.001, n=
80, Mann−Whitney Rank Sum test). The positive CO2-dependent
DC deﬂection was 3.1 (2.6, 3.4) mV (n=95) as recorded with
intracortical microelectrodes. Using the empirical formula of Tschirgi
and Taylor as mentioned above (Tschirgi and Taylor, 1958), we
calculated a positive CO2-dependent intracortical DC deﬂection of
29 (±5)∗(0.192−0.091)=2,9 (2.4, 3.4) mV which included the em-
pirical value above and thus conﬁrmed the ﬁndings by Tschirgi and
Taylor. Moreover, Tschirgi and Taylor had found a slope of about
17 mV/pH unit for the linear relationship between the positive
intracortical CO2-dependent DC deﬂection and the arterial pH. OurFig. 5. Comparison between the CO2-dependent intracortical DC deﬂections in vitro and in viv
O2, 20% CO2 and 0% N2) induced a small negative intracortical DC deﬂection in contrast to
deﬂection in the slices might be generated by astrocytes in contrast to the positive CO2-dep
(6: Why the CO2-dependent intracortical DC deﬂection is not of astrocytic origin). The intracort
the brain slices. The small superscript numbers at the beginning of the traces indicate two di
gas mixture containing 21% O2, 10% CO2, and 69% N2 as indicated by the increase in ende
hypercapnia, pH decreased signiﬁcantly but [K+]o did not change in vivo. The small superscﬁndings corresponded to a slope of 16.1 mV/pH unit which is very
similar.
DHC-induced BBB opening to albumin is neither associated with a
measureable increase of baseline [K+]o nor a change in the
CO2-dependent intracortical DC deﬂection (preparation type 2)
To test the hypothesis that BBB opening to macromolecules such
as albumin is associated with (i) BBB opening to small molecules
such as potassium, (ii) disappearance of the potential difference be-
tween intravascular and interstitial space, and, hence, (iii) disappear-
ance of the CO2-dependent intracortical DC deﬂection, the bile salt
DHC was topically applied to the brain at a concentration of 2 mM
(n=9). At this comparably low concentration, DHC causes Evans
blue dye extravasation and has no obvious acute neurotoxic effects
in vivo or in vitro (Seiffert et al., 2004). Before DHC application, the re-
sponse to hypercapnia was tested twice at an interval of 30 min.
Then, Evans blue was given intravenously followed by brain topical
application of DHC for 90 min. A third hypercapnic episode was in-
duced at 90 min. There were no signiﬁcant differences in paCO2,
paO2, arterial pH or MAP between the three hypercapnic episodes
(one way repeated measures analysis of variance). Moreover, no dif-
ference was detected between the three hypercapnia-induced
intracortical DC-deﬂections (1st hypercapnia: 2.9 (2.7, 3.4) mV, 2nd
hypercapnia: 2.8 (2.5, 3.1) mV, 3rd hypercapnia under DHC: 2.9
(2.8, 3.3) mV, n=9, one way repeated measures analysis of variance,
Fig. 6A). During DHC application, rCBF increased slowly and signiﬁ-
cantly from 105 (99, 106) % to 139 (132, 177) % (P=0.006, n=8,
Paired t-test) but this was also the case in the control group in
which rCBF increased from 104 (97, 113) % to 147 (116, 170) %
(P=0.030, n=7, Paired t-test). Possibly, this was due to a slight
decline in sedation depth since, after pooling the data of both the con-
trol and DHC group, the power of the spontaneous activity signiﬁ-
cantly increased over time from 5.5 (3.8, 7.0) to 7.7 (5.0, 12.3) mV2o. (A) In brain slices, hypercapnia (bars, change from 80% O2, 5% CO2, and 15% N2 to 80%
the positive DC deﬂection in vivo (B). This negative CO2-dependent intracortical DC
endent intracortical DC deﬂection in vivo as explained in the Supplemental Discussion
ical pH decreased and [K+]o increased signiﬁcantly during the hypercapnic episodes in
fferent microelectrodes in the slice. (B) In vivo, hypercapnia (arrows, ventilation with a
xperitory pCO2) induced a positive intracortical DC deﬂection. At this mild degree of
ript numbers indicate two different microelectrodes in the tissue.
Fig. 6. Topical application of DHC to the brain. (A) Two hypercapnic episodes (indicated by the steep increase in end-expiratory pCO2) were induced as controls at an interval of
30 min before DHC was applied to the brain. Subsequently, Evans blue was given intravenously (compare Supplemental Fig. 1B for the experimental paradigm) which led to a shal-
low, transient DC positivity. After 90 min of superfusion with DHC, a third hypercapnic episode was induced. The CO2-dependent intracortical DC deﬂection after DHC was not dif-
ferent from the two CO2-dependent DC deﬂections before DHC. (B) Coronal section which shows the Evans blue dye extravasation in the cranial window area after topical
application of DHC (bluish area). The Evans blue extravasation was assessed by calculating the target to background ratio of relative Evans blue extravasation in the area of the
cranial window (target, blue square) compared to the corresponding region of the contralateral hemisphere (background, contralateral white square). The two white squares at
the bottom indicate two regions which were provided by the algorithm and used to normalize the median light intensity of each hemisphere. (C) The difference in the target to
background ratio was signiﬁcant between sham controls (n=6) and animals treated with topical DHC (n=9) (*P=0.002, Mann–Whitney rank sum test).
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and baseline [K+]o were observed neither during DHC application nor
during the corresponding time interval in the control group
(Wilcoxon Signed Rank tests). Speciﬁcally, baseline [K+]o was 2.9
(2.7, 3.5) before and 3.0 (2.6, 3.4) mM after DHC application (n=6).
BBB opening to albumin was assessed by calculating the target to
background ratio of relative Evans blue dye extravasation in the cra-
nial window region compared to the corresponding region of the con-
tralateral hemisphere (Figs. 6B and C). Brain topical application of
DHC led to a signiﬁcant increase in Evans blue extravasation (target
to background ratio: 1.44 (1.37, 1.49), n=9) compared to the sham
operated group (target to background ratio: 1.12 (1.11, 1.14), n=6)
(P=0.002, Mann–Whitney Rank Sum test) similar to previous obser-
vations (Seiffert et al., 2004).
Mannitol-induced BBB opening to albumin is neither associated with
an increase in baseline [K+]o nor a change in the CO2-dependent
intracortical DC deﬂection (preparation type 1)
In 16 animals, mannitol (1.6 M, 1 ml) was administered via
the right carotid artery to open the BBB transiently in the vascular ter-
ritory of this artery. While mannitol was applied, Evans blue was al-
ready present intravenously to allow us the quantiﬁcation of the
local BBB opening to albumin ex vivo later on. Mannitol led to an acid-
iﬁcation of the blood to a pH of ~7.1 as measured ex vivo and induced
a signiﬁcant, transient positive DC deﬂection of 2.1 (1.7, 2.8) mV
(Pb0.001, Paired t-test) and a signiﬁcant, transient rise in rCBF from
110 (96, 138) to 544 (277, 655) % (Pb0.001, Mann–Whitney Rank
Sum Test) after application to the carotid artery (Figs. 7A and B). No
change in baseline [K+]o was observed, but six animals generated
SD in response to mannitol as shown in Fig. 7B. This was never ob-
served in response to intracarotideal application of physiologicalNaCl (n=16). The SD in response to mannitol was characterized by
a sharp negative intracortical DC-shift of −11.3 (−13.8, −9.7) mV
lasting for 42 (41, 50) s and a steep rise in [K+]o to 31.4 (22.8, 43.9)
mM. The latency of these changes in DC potential and [K+]o was 40
(27, 58) s between the two microelectrodes, indicating a spread typ-
ical of SD (Fig. 7C).
The positive CO2-dependent intracortical DC deﬂections before and
after mannitol application were not different in either animals
displaying or not displaying SD (animals displaying SD, ﬁrst and second
hypercapnia before mannitol and third hypercapnia after mannitol: 3.7
(3.3, 3.9)mV versus 4.2 (3.7, 4.2)mV versus 4.1 (4.0, 5.0)mV, n=5, one
way repeated measures analysis of variance) (animals not displaying
SD,ﬁrst and secondhypercapnia beforemannitol and third hypercapnia
after mannitol: 3.1 (3.1, 3.2) mV versus 3.3 (2.9, 3.4) mV versus 3.7 (3.4,
4.2) mV, n=9, one way repeated measures analysis of variance).
We then determined separately the target to background ratio of
relative Evans blue dye extravasation between the ipsi- and contralat-
eral hemisphere for animals which had or, respectively, had not
displayed SD in response to mannitol (Fig. 7D). Moreover, we
performed ﬁve additional experiments in which SD was triggered
by droplets of 300 mM KCl solution at a remote window but no man-
nitol was applied into the carotid artery. Animals which had not
displayed SD in response to mannitol showed statistically signiﬁcant
Evans blue dye extravasation in the ipsilateral hemisphere (target to
background ratio: 1.05 (1.02, 1.11), P=0.003, n=9, Mann–Whitney
Rank Sum Test) in a similar fashion to animals in which SD was trig-
gered by KCl but no mannitol was given (target to background ratio:
1.04 (1.02, 1.05), P=0.027, n=5, Paired t-test). However, animals
which displayed SD in response to mannitol showed a signiﬁcantly
larger target to background ratio than the other two groups (target
to background ratio: 1.34 (1.17, 1.44), P=0.05, n=6, Kruskal–Wallis
one way analysis of variance on ranks with Dunn's post-hoc test).
Fig. 7. Intracarotideal application of mannitol. After two hypercapnic control episodes (as indicated by the steep increase in end-expiratory pCO2) and intravenous administration of
Evans blue, mannitol was applied into the carotid artery (compare Supplemental Fig. 1C for the experimental paradigm). (A) Mannitol (arrow) led to a signiﬁcant positive
intracortical DC deﬂection and a large, short-lasting increase in rCBF. The CO2-dependent intracortical DC deﬂection remained unaltered after mannitol application compared to
the two hypercapnic control episodes. (B) In six animals intracarotideal mannitol injection caused an SD (*) characterized by a sharp negative intracortical DC shift and a steep
transient increase in [K+]o. The CO2-dependent intracortical DC deﬂection remained unaltered after mannitol application compared to the two hypercapnic control episodes.
(C) The intracortical DC/AC-ECoG and [K+]o changes during SD are given at a higher temporal resolution to show the propagation of the SD between the two microelectrodes.
(D) Prominent Evans blue extravasation in the ipsilateral hemisphere (blue area) after intracarotideal application of mannitol.
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All tools for the assessment of BBB function in vivo are subject to
constraints by the complexity of the in vivo situation. This applies in
particular to the assessment of the electrical barrier and has led to a
number of in vitro models of BBB ion transport (Keep et al., 1993).
However, to conﬁrm and understand the physiological and patho-
physiological signiﬁcance of the results of such in vitro studies, it is ul-
timately necessary to return to in vivo models. Application of DHC
into the carotid artery has been proposed as such an in vivo model
(Spigelman et al., 1983) which could be of particular interest to
study the electrophysiological stigmata of electrical barrier disruption
(Nita et al., 2004). Our experiments in rats cast however doubt on this
hypothesis because we recorded changes in rCBF and intracortical po-
tentials typical of focal cerebral ischemia following intracarotideal
DHC, and our morphological assessment of the brains showed a
thrombosis of the middle cerebral artery. Severe damage of the endo-
thelium by the high concentration of the bile salt DHC in the cerebral
arteries might have led to endothelial injury and a consequent throm-
bosis (Lossinsky et al., 1995). We cannot say with certainty that a
similar thrombotic process also occurred in the previous study in
cats (Nita et al., 2004) but the reported electrophysiological anoma-
lies could reﬂect an ischemic process which is further discussed
in the Supplemental Discussion (2: Electrophysiological anomalies
following intracarotideal DHC in cats and rats).
These observations suggest that intracarotideal DHC is not a suit-
able model to selectively study the potential changes following the
opening of the electrical barrier and they also illustrate an important
pitfall when in vitro work on the BBB is translated into in vivo work,
which is the induction of ischemic stroke as a consequence of severe
damage to the BBB (Lossinsky et al., 1995).Morphological evidence that BBB dysfunction develops in a
hierarchical fashion
According to previous electron microscopic studies, BBB dysfunc-
tion to hyperosmolar agents develops in a hierarchical fashion in
which, ﬁrst, the transcellular pathway is disturbed, causing increased
brain inﬂux of macromolecules, whereas the impairment of the
paracellular pathway only constitutes the severe degree of damage
(Farrell and Shivers, 1984; Houthoff et al., 1982; Lossinsky et al.,
1995). Only the latter should be associated with the opening of the
electrical barrier.
In support of such a hierarchy of damage, a recent tracer study in-
dicated that it is not possible to grade the dysfunction of the BBB
according to the size of trespassing molecules. Thus, the signal en-
hancement by Gadoﬂuorine M, a gadolinium formulation which
binds quantitatively to albumin, extended beyond the lesion, but sig-
nal enhancement by gadolinium diethylenetriamine-pentaacetic acid
(Gd-DTPA), a comparably small molecule without binding afﬁnity to
albumin, was restricted to the lesion, when the compounds were
injected within 24 h following photothrombosis in rats (Stoll et al.,
2009).
Moreover, a previous study in adult viable pericyte-deﬁcient
mouse mutants indicated that the transcellular pathway can be
severely disturbed in the presence of an intact paracellular path-
way (Armulik et al., 2010). This study found a marked increase in per-
meability of the BBB to water and a range of low- and high-
molecular-mass tracers due to a selective increase in endothelial
transcytosis while the integrity of the endothelial junctions was
retained.
In the present paper, we investigated whether functional evidence
can be found for this hierarchy of damage. The intactness of the elec-
trical barrier was assessed using two functional tests, the stability of
[K+]o and the CO2-dependent intracortical DC deﬂection.The electrical barrier can remain closed for potassium despite signiﬁcant
extravasation of Evans blue
In the Supplemental Discussion (3: Why the potassium equilibrium
potential across the BBB implies an electrochemical driving force for po-
tassium from the intravascular to the extracellular compartment) it is
explained in detail why the trans-BBB gradient in potassium from
~5 mM intravascularly to ~3 mM interstitially leads to an electro-
chemical driving force for potassium from the intravascular to the in-
terstitial compartment. This electrochemical driving force implies
that an increase in [K+]o should be detectable when tight junctions
open. However, we did not observe such an increase in [K+]o when
we either applied DHC topically to the brain or mannitol into the ca-
rotid artery although the tissue displayed signiﬁcant extravasation of
Evans blue (Figs. 6 and 7). These ﬁndings hence provide functional
evidence that opening of the BBB to macromolecules can occur with-
out simultaneous opening to small ions such as potassium, consistent
with the previous electron microscopic ﬁndings of intact tight junc-
tions despite signiﬁcant morphological anomalies of the transcellular
pathway, when the BBB dysfunction was mild to moderate following
the exposure to hyperosmolar solutions (Farrell and Shivers, 1984;
Houthoff et al., 1982; Lossinsky et al., 1995).
The caveat is added that astrocytes could potently buffer the po-
tassium preventing the increase in [K+]o although the electrical bar-
rier is open. However, when the electrical barrier opens, the amount
of potassium spilled into the interstitial space would be marked and
continuous. There are other conditions such as electrical stimulation
during which an increase in [K+]o is detected by the usual double-
barreled ion-selective microelectrodes with a tip diameter of 3 μm
although astrocytes are functional. Why should an increase in [K+]o
be undetectable when the potassium is derived from the blood in-
stead of neurons? It could be argued that the electrical barrier opened
too slowly in the experiments in which DHC was topically applied
and this gave astrocytes enough time to adapt to the brain inﬂux of
potassium but this argument does not hold for the intracarotideal ap-
plication of mannitol (Lossinsky et al., 1995). We cannot exclude with
absolute certainty that [K+]o only increased in tissue patches where
no microelectrodes were placed (Somjen et al., 1991). But, we believe
this is not very likely because we did not ﬁnd an increase in [K+]o in
any of the 16 experiments with intracarotideal mannitol and the six
experiments with topical DHC in which two potassium-selective mi-
croelectrodes were positioned in the interstitial space.
Interestingly, mannitol induced SD in a fraction of experiments.
The possible mechanisms underlying this observation are further
discussed in the Supplemental Discussion (4: The induction of SD by
mannitol).
The CO2-dependent intracortical DC deﬂection
In the present study, both the experiments in brain slices and the
negative results of the pharmacological experiments in vivo strongly
supported the prevailing view that the CO2-dependent intracortical DC
deﬂection is not generated by neurons or astrocytes (Lehmenkühler
et al., 1999; Voipio et al., 2003; Woody et al., 1970). This is further
explained in detail in the Supplemental Discussion (5: Why the CO2-
dependent intracortical DC deﬂection is not of neuronal origin; 6: Why
the CO2-dependent intracortical DC deﬂection is not of astrocytic origin).
Instead there appears to be general agreement that the CO2-dependent
intracortical DC deﬂection is generated at the BBB and that, speciﬁcally
in rats, similarly to rabbits, goats and dogs, it is a diffusion potential re-
lated to the proton gradient across the BBB on which it depended in a
linear fashion in previous studies (Held et al., 1964; Messeter and
Siesjo, 1971; Tschirgi and Taylor, 1958). The arguments for this hypoth-
esis are presented in the Supplemental Discussion (7: Generation of the
CO2-dependent intracortical DC deﬂection at the BBB) based on the
present and previous observations.
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the carotid artery, we did not ﬁnd any decline in the CO2-dependent
intracortical DC deﬂection although the tissue displayed signiﬁcant
Evans blue dye extravasation. If tight junctions had opened for small
ions including protons, a decline should have been detectable. This ﬁnd-
ing hence provides additional evidence, independent of the measure-
ments of [K+]o, that the electrical barrier remained intact.
The caveat could be added that the opening of the electrical barrier
could have been so short-lasting that we missed it when we exposed
the animals to hypercapnia a few minutes after the intracarotideal
application of mannitol. However, mannitol led to an acidiﬁcation of
the blood. Consistently, mannitol caused a signiﬁcant, short-lasting,
positive intracortical DC deﬂection during its application. If the electri-
cal barrier had opened during this period, we should have seen a nega-
tive rather than a positive DC potential because the extracellular
compartment is electropositive to the intravascular compartment
under normal resting conditions (Held et al., 1964; Messeter and
Siesjo, 1971; Revest et al., 1994). This makes it very unlikely that we
missed a short-lasting opening of the electrical barrier. Moreover, earli-
er reports indicated that the dysfunction of the BBB following mannitol
recovers only slowly, after an hour or more (Hardebo, 1980; Rapoport
et al., 1980; Somjen et al., 1991).
At least partially, the acidiﬁcation of the blood might have also been
responsible for the marked increase in rCBF during application of man-
nitol because acidosis causes vasodilation, and vasodilation increases
rCBF (Lindauer et al., 2003). Alternatively, BBB dysfunction could have
been responsible for this acute increase in rCBF. Our DHC experiments
were however not consistent with the latter hypothesis. In contrast to
the mannitol experiments, the increase in rCBF following topical appli-
cation of DHC to the brain was not larger than the rCBF increase in the
control experiments. The relationship between BBB dysfunction and
rCBF, the implications of rCBF changes for measurements of the
transendothelial electrical resistance and possible interactions between
rCBF and our recordings of extracerebral potentials are further
discussed in the Supplemental Discussion (8: BBB dysfunction and
rCBF, implications of changes in rCBF for the transendothelial electrical
resistance; 9: Interactions between rCBF and DC potential changes).Conclusion
In the present study, we found further evidence that the CO2-
dependent intracortical DC-deﬂection is generated at the BBB,
which provides a simple and robust tool to test the integrity of the
electrical barrier in rats in vivo. Notably, our data indicate that open-
ing of the BBB to macromolecules such as albumin is not necessarily
associated with free permeability of the BBB to small ions such as po-
tassium and protons and a short-circuit between intravascular and in-
terstitial space, respectively. Our data hence appear to conﬁrm a
hierarchy of damage previously found in electron microscopic studies
in which the dysfunction of the transcellular pathway preceded the
dysfunction of the paracellular pathway (Farrell and Shivers, 1984;
Houthoff et al., 1982; Lossinsky et al., 1995). Clinically, this implies
that changes in paCO2 may induce cerebral DC potential changes in
patients with acute cerebral injuries although neuroimaging studies
indicate BBB dysfunction. CO2-dependent DC deﬂections could partic-
ularly confound the assessment of ultraslow injury potentials which
are increasingly important in the neuromonitoring of patients on
the intensive care unit because they appear to indicate the occurrence
of a new stroke (Dreier et al., 2013; Drenckhahn et al., 2012). More-
over, we suggest that severe BBB damage is an etiology of ischemic
stroke and may be an important obstacle for strategies of drug
targeting in the brain which aim at the opening of the BBB. This de-
serves further careful experimental and clinical studies.
Supplementary data to this article can be found online at http://
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